Neuralink co-founder and Science founder Max Hodak recently discussed groundbreaking developments in brain-computer interfaces (BCI) with Y Combinator CEO Gary Tan. Hodak detailed how Science's technology has restored coherent vision to blind patients and explored how BCI could fundamentally reshape human consciousness and longevity.

Key insights from the conversation include:

1. BCI technology is entering an "exponential growth phase," evolving from single applications to a broad category comparable to pharmaceuticals, with potential ranging from vision restoration to digital drugs and consciousness integration.

2. Science's Prima implant has enabled over 40 blind individuals to perceive coherent images—the first time shaped visual perception has been artificially created in the human brain.

3. The brain functions as a computer encased in skull, with AI and neuroscience converging toward unification. The "latent space" within AI models shows remarkable similarity to how the brain processes information.

4. Future "bio-hybrid" interfaces may grow living neurons within the brain to establish high-bandwidth connections, resembling the neural queues seen in Avatar.

Restoring Vision: From Drug Discovery to Neural Engineering Hodak emphasized that biotechnology has transitioned from incremental progress to nonlinear breakthroughs. Science's Prima implant—a 2mm x 2mm silicon chip placed beneath the retina—works with camera-equipped glasses and a laser projector to stimulate bipolar cells directly. Unlike previous solutions that only produced random light flashes (phosphenes), Prima generates meaningful imagery.

Hodak highlighted the advantage of neural engineering over traditional drug development: instead of addressing cellular degeneration causes, it directly inputs signals into the brain's computational system.

The Convergence of AI and Neuroscience: The Brain's Latent Space As a computer scientist, Hodak views the brain as an information-processing system distinct from von Neumann architecture computers. He noted that AI advancements are accelerating neuroscience through:

- Latent Space Alignment: Internal representations in trained AI models closely mirror how brain regions like the inferior temporal cortex process objects and faces.

- Brain as API: Sensory inputs (optic nerve, spinal nerves) function as the brain's application programming interfaces. BCI essentially leverages these APIs for bidirectional communication.

Hodak criticized dismissive views of AI as "stochastic parrots," asserting that neuroscience and AI are undergoing deep integration.

Next-Generation Frontiers: Bio-Hybrid Interfaces and Artificial Nerves Hodak envisions bio-hybrid neural interfaces surpassing current electrode-based stimulation within 5-10 years:

- Evolutionary Engineering: Instead of implanting metal wires, Science aims to cultivate stem cell-induced neurons that integrate naturally with existing brain tissue.

- Low Immunogenicity: Genetically engineered neurons could evade immune detection, enabling universal grafts without customization.

- Avatar-like Connections: This technology might create new neural pathways, such as direct internet-connected nerve bundles enabling profound human-machine consciousness coupling.

Science's parallel project, Vessel, focuses on miniaturizing complex life-support systems like ECMO into portable "destination therapy" devices.

Entrepreneurial Insights: From Software to Wetware Reflecting on his Neuralink experience, Hodak described it as the "ultimate entrepreneurship PhD." He credited Elon Musk's early recognition of AI risks and the necessity of human enhancement through BCI.

For aspiring entrepreneurs, Hodak recommended:

- High Agency: Pursue unconventional paths to access top laboratories or projects.

- Oral Tradition: Seek early opportunities to work with visionary leaders like Musk to gain industry perspective and unwritten rules.

The 2035 "Event Horizon" Hodak concluded with a striking prediction: people alive today might live to 1,000 years. By 2035, he anticipates an "event horizon" where AI and BCI collectively redefine human conditions. BCI adoption will progress from treating severe disabilities to addressing normal aging and ultimately enhancing human capabilities. When implants offer enviable abilities—like direct internet access or supersensory experiences—risk-benefit calculations will shift fundamentally.

Future applications could include "digital sleeping pills" or "digital stimulants" using ultrasound to modulate brain states, potentially replacing chemical drugs. Hodak believes technology will soon reach an unpredictable inflection point that rewrites human and machine interfaces.